Amrubicin improved response rate and progression-free survival vs. topotecan in Phase III trial
There are 2 comments on the EurekAlert! story from Jul 7, 2011, titled Amrubicin improved response rate and progression-free survival vs. topotecan in Phase III trial. In it, EurekAlert! reports that:
Lung cancer patients given amrubicin as a second-line therapy had a significantly improved response rate and longer progression-free survival than patients treated with topotecan , according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer .
Join the discussion below, or Read more at EurekAlert!.
#1 May 12, 2013
I have an elderly uncle who suffers from lung cancer.
Unfortunately despite the fact that this is the most
common cancer in China we still do not have access to
Calsed(Amrubicin). The doctor gave us a prescription
but the only way we can get it is from abroad. We are
stil looking for a reliable place...
#2 May 13, 2013
I used this pharmacy isrameds that we found online when my father needed amrubicin. We were very pleased with them and they even accepted our doctors prescription from Bulgaria.
Add your comments below
|Mother, Aunt and brother all had NSCC - should ...||Aug '17||Krissyy||1|
|What do the real lung cancer symptoms feel like?!? (Oct '06)||Aug '17||Dmzabo||59|
|We could do more to fight cancer like McCain's....||Aug '17||yidfellas v USA||49|
|Can lung cancer look like pneumonia on x-rays? (Jan '07)||Aug '17||Hurleyjmw||182|
|Building Canada 150 - Asbestos: from miracle ma...||Jul '17||Day in UK||1|
|my soninlaws stage 4 lung cancer miracle (Aug '06)||Jun '17||Sassyk||203|
|1 in 2 Canadians will get cancer, 1 in 4 will d...||Jun '17||Anonymous||2|
Find what you want!
Search Lung Cancer Forum Now
Copyright © 2017 Topix LLC